Dr. Paul L. Baron

Paul L. Baron, MD, is Chief of breast surgery and Director of the breast cancer program at Lenox Hill Hospital. An accomplished breast surgical oncologist, Dr. Baron specializes in high risk patients and oncoplastic surgery. His goals are to oversee the expansion and enhancement of the hospital s breast surgery services and it's multidisciplinary breast cancer program. The Breast Cancer Center of the Northwell Health Cancer Institute, is one of the largest oncology programs in the New York metro area.

Throughout his career, Dr. Baron has actively engaged in advancing the field of oncology. He has published more than 120 articles and abstracts on various cancer-related topics and has been invited to speak at more than 60 national conferences. He has received more than $3.3 million in grant funding for medical research from such high-profile sources as the American Cancer Society and the Department of Defense and holds two patents in the area of cancer diagnosis and treatment. He is affiliated with numerous distinguished professional societies, including The American College of Surgeons, The Society of Surgical Oncology and The American Society of Breast Surgeons, where he serves on the board of directors. He also serves on the Board of Directors of the National Accreditation Program for Breast Centers (NAPBC).

Dr. Baron earned both his undergraduate and medical degrees from Boston University's six-year medical program. He completed his internship and residency in general surgery at the Medical College of Virginia, where he served as chief surgery resident during his final year. He subsequently pursued a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center and was honored with the American Cancer Society s Clinical Oncology Fellowship Award for his work.

Dr. Baron is rated as an Experienced provider by MediFind in the treatment of Lymphangiectasis. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy.

His clinical research consists of co-authoring 36 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.